Table 2 Main characteristics of the 38 patients with bullous HSP
From: Hemorrhagic bullous lesions in Henoch-Schönlein purpura: a case report and review of the literature
Children | Percentage (%) | |
|---|---|---|
Sex | ||
Male | 19 | 50 |
Female | 19 | 50 |
Male/female ratio | 1:1 | |
Age (years) | ||
Mean± SD | 8.2± 3.32 | |
Systemic symptoms | ||
Joint involvement | 24 | 63.2 |
GI involvement | 23 | 60.5 |
Renal involvement | 15 | 39.5 |
Scrotum involvement | 1 | 2.6 |
No systemic symptom | 1 | 2.6 |
Skin biopsy | 19 | 50 |
Positive of IgA deposition | 12 | 31.6 |
Negative of IgA deposition | 7 | 18.4 |
Therapy | ||
Systemic corticosteroid use | 22 | 57.9 |
Topical corticosteroid use | 3 | 7.9 |
Azathioprine | 2 | 5.3 |
Colchicine | 1 | 2.6 |
Dapsone | 1 | 2.6 |
No treatment | 9 | 23.7 |
No reported | 1 | 2.6 |
Outcome | ||
Resolved | 22 | 57.9 |
Hyperpigmentation | 4 | 10.5 |
Scarring | 6 | 15.8 |
Hematuria | 2 | 5.3 |
Proteinuria | 1 | 2.6 |
Recurrence | 2 | 5.3 |
No reported | 5 | 13.2 |